The Longevity Letter
Home
Archive
Search
Sign in
Subscribe
The Longevity Letter
Two supplements I like. One I don't.

Two supplements I like. One I don't.

Vitamin D made me rethink both dose and K2. Creatine disrupts my sleep. NR still has better biomarker data than outcome data.

Hillary Lin, MD

•

Sep 3, 2026


Peptides get the hype. These amino acids get the results.

Peptides get the hype. These amino acids get the results.

The leucine paradox, the $20 GlyNAC stack, and why your protein shake math changes at 50.

Apr 8, 2026

•

24 min read

Your Biological Age Test Might Be Lying to You

Your Biological Age Test Might Be Lying to You

Mar 23, 2026

•

30 min read

Subscribe to The Longevity Letter

Join the list to receive our newest posts straight to your inbox.

Latest


Two supplements I like. One I don't.

Two supplements I like. One I don't.

Why I broke up with fibermaxxing

Why I broke up with fibermaxxing

I Raised My Omega-3 Level. Then I Read the Trials.

I Raised My Omega-3 Level. Then I Read the Trials.

The Recall Is Over. What If the Illness Isn't?

The Recall Is Over. What If the Illness Isn't?

Five Meal-Timing Myths That Are Costing You Muscle

Five Meal-Timing Myths That Are Costing You Muscle

Inflammation Is Not One Thing. So Which Test Do You Need?

Inflammation Is Not One Thing. So Which Test Do You Need?

Peptides won an FDA committee vote. I think that was the right call.

Peptides won an FDA committee vote. I think that was the right call.

A Pill That Lowers LDL Nearly 60%: Would I Switch?

A Pill That Lowers LDL Nearly 60%: Would I Switch?


The Longevity Letter

Hype-free longevity and healthspan protocols from a Stanford-trained MD.

Home

Subscribe

Archive

Login

Reset Password

Update Password

Profile

Search

© 2026 The Longevity Letter.
beehiivPowered by beehiiv